GRAIL, Inc. (GRAL)
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Sector: Services-Medical Laboratories
Industry: Medical - Diagnostics & Research
GRAIL Inc.
NASDAQ:GRALHealthcare · Medical - Diagnostics & Research
-9.75%$143.43
AH$144.00+0.40%vs close
Mkt Cap$6.41B
Float42.42M
O/S44.67M
Vol
$ Vol
RVOL
Inst Own85.7%
SI19.3%
Earnings
Dilution
Financials Summary
Revenue$147.17M
Net Income-$408.35M
Total Assets$2.92B
Free Cash Flow-$299.01M
Debt & Equity
Debt 4%
Equity 96%
Total Debt$98.01M
Total Equity$2.58B
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in GRAL's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$2.92B
Liabilities$344.15M
Accounts Receivable$18.3M
Accounts Payable$2.08M
Inventory$16.02M
PP&E (Net)$103.88M
Goodwill$0
Intangible Assets$1.85B
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Revenue | $147.17M | $125.59M | $93.11M | $55.55M | $14.61M | $0 | $0 | $0 |
| YoY Growth | 17.2% | 34.9% | 67.6% | 280.2% | - | - | - | - |
| Cost of Revenue | $209.75M | $203.62M | $188.72M | $172M | $114.61M | $0 | $0 | $0 |
| Gross Profit | -$62.57M | -$78.02M | -$95.61M | -$116.45M | -$100M | $0 | $0 | $0 |
| Gross Margin | -42.5% | -62.1% | -102.7% | -209.6% | -684.4% | - | - | - |
| Research and Development | $195.79M | $322.38M | $338.75M | $329.58M | $460.21M | $192.91M | $167.09M | $223.16M |
| Selling, General, and Administrative | $275.8M | $367.82M | $362.56M | $296.44M | $234.06M | $123.51M | $88.58M | $64.34M |
| Other | $0 | $1.42B | $718.47M | $4.7B | $471.07M | $0 | $0 | $0 |
| Total Operating Expenses | $471.59M | $2.11B | $1.42B | $5.33B | $1.17B | $316.42M | $255.66M | $287.5M |
| Operating Income (EBIT) | -$534.16M | -$2.19B | -$1.52B | -$5.44B | -$1.27B | -$316.42M | -$255.66M | -$287.5M |
| Operating Margin | -363.0% | -1743.0% | -1627.6% | -9798.2% | -8659.6% | - | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $28.65M | $26.73M | $7.95M | $1.74M | $332K | $6.14M | $12.43M | $8.34M |
| Other Income (Expense) | -$341K | $26.8M | $7.75M | $1.5M | $90K | $4.29M | $10.61M | $12.26M |
| Income Before Tax (EBT) | -$534.5M | -$2.16B | -$1.51B | -$5.44B | -$1.27B | -$312.12M | -$245.05M | -$275.23M |
| Income Tax Expense | -$126.15M | -$135.36M | -$41.95M | -$42.29M | -$17.48M | $33K | -$195K | $485K |
| Net Income | -$408.35M | -$2.03B | -$1.47B | -$5.4B | -$1.25B | -$312.16M | -$244.85M | -$275.72M |
| Net Income Margin | -277.5% | -1613.9% | -1574.2% | -9719.3% | -8539.4% | - | - | - |
| Supplementary Data | ||||||||
| EPS | -11.11 | -63.54 | -47.20 | -173.87 | -40.18 | -2.52 | -1.99 | -2.42 |
| Diluted EPS | -11.11 | -63.54 | -47.20 | -173.87 | -40.18 | -2.52 | -1.99 | -2.42 |
| Weighted Average OS | 36.75M | 31.90M | 31.05M | 31.05M | 31.05M | 123.67M | 123.19M | 114.14M |
| EBITDA | -$378.16M | -$610.17M | -$638.22M | -$587.7M | -$1.21B | -$308.73M | -$243.14M | -$269.42M |
| EBITDA Margin | -257.0% | -485.8% | -685.5% | -1058.0% | -8259.0% | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Assets | ||||||||
| Current Assets | ||||||||
| Cash and Cash Equivalents | $249.73M | $214.23M | $97.29M | $241.6M | $221.16M | $170.19M | $143.19M | $95.09M |
| Short-Term Investments | $654.7M | $549.24M | $0 | $0 | $0 | $413.29M | $401.15M | $546.26M |
| Cash and Short-Term Investments | $904.43M | $763.47M | $97.29M | $241.6M | $221.16M | $583.48M | $544.34M | $641.35M |
| Accounts Receivable | $18.3M | $24.64M | $22.35M | $18.61M | $6.88M | $0 | $0 | $0 |
| Inventory | $16.02M | $18.63M | $21.7M | $19.75M | $0 | $0 | $0 | $0 |
| Other Current Assets | $15.11M | $0 | $0 | $0 | $6.89M | $0 | $0 | $0 |
| Total Current Assets | $953.85M | $819.86M | $156.06M | $295.63M | $242.73M | $595.92M | $557.51M | $649.23M |
| Long-Term Assets | ||||||||
| Property, Plant & Equipment Net | $103.88M | $135.43M | $169.38M | $198.72M | $216.37M | $101.39M | $59.46M | $33.04M |
| Goodwill | $0 | $0 | $888.94M | $1.5B | $6.2B | $0 | $0 | $0 |
| Intangible Assets | $1.85B | $2.02B | $2.69B | $2.94B | $3.07B | $0 | $0 | $0 |
| Long-Term Investments | $6.97M | $0 | $4.22M | $4.53M | $0 | $2.05M | $15.16M | $1.63M |
| Deferred Tax Assets | $0 | $0 | $643.11M | $664.12M | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $6.75M | $11.12M | $7.98M | $6.14M | $7.1M | $6.94M | $3.38M | $2.94M |
| Total Long-Term Assets | $1.97B | $2.16B | $4.4B | $5.31B | $9.5B | $110.38M | $78.01M | $37.61M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $2.92B | $2.98B | $4.56B | $5.6B | $9.74B | $706.3M | $635.52M | $686.85M |
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts Payable | $2.08M | $4.84M | $19.67M | $17.48M | $17.65M | $24.51M | $6.09M | $12.75M |
| Short-Term Debt | $11.71M | $0 | $14.81M | $13.34M | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $1.6M | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $65.87M | $22.69M | $87.64M | $65.96M | $4.51M | $12.41M | $23K | $267K |
| Total Current Liabilities | $79.67M | $76.92M | $163.61M | $134.94M | $97.89M | $83.97M | $44.93M | $74.16M |
| Long-Term Liabilities | ||||||||
| Long-Term Debt | $43.15M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $218.58M | $345.86M | $676.03M | $735.19M | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | -$40.4M | $2.24M | $1.5M | $3.13M | $112.76M | $2.95M | $3.42M | $11.52M |
| Total Long-Term Liabilities | $264.48M | $402.98M | $747.13M | $821M | $209.51M | $60.49M | $40.06M | $12.32M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $344.15M | $479.9M | $910.74M | $955.94M | $307.4M | $144.46M | $84.99M | $86.47M |
| Stockholders' Equity | ||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $1.99B | $1.76B | $1.6B |
| Common Stock | $40K | $34K | $11.42B | $10.96B | $10.34B | $151K | $138K | $129K |
| Retained Earnings | -$10.21B | -$9.8B | -$7.78B | -$6.31B | -$911.54M | -$1.62B | -$1.31B | -$1.06B |
| Comprehensive Income & Other | $2.65M | $1.45M | $1.07M | $894K | $315K | $3.6M | $2.46M | $128K |
| Other Stockholders' Equity | $12.79B | $12.31B | $1.07M | $894K | $315K | $2.18B | $1.86B | $1.66B |
| Total Equity | $2.58B | $2.5B | $3.65B | $4.65B | $9.43B | $561.84M | $550.53M | $600.37M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $2.92B | $2.98B | $4.56B | $5.6B | $9.74B | $706.3M | $635.52M | $686.85M |
| Supplementary Data | ||||||||
| Total Debt | $98.01M | $68.14M | $84.41M | $96.01M | $110.56M | $62.99M | $42.04M | $2.52M |
| Net Debt | -$151.72M | -$146.09M | -$12.88M | -$145.59M | -$110.6M | -$107.21M | -$101.15M | -$92.57M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Operating Activities | ||||||||
| Net Income | -$408.35M | -$2.03B | -$1.47B | -$5.4B | -$1.25B | -$312.16M | -$244.85M | -$275.72M |
| Depreciation & Amortization | $156.34M | $158.06M | $158.7M | $154.76M | $58.45M | $7.56M | $10.31M | $14.08M |
| Deferred Income Tax | -$126.15M | -$134.25M | -$38.15M | -$39.06M | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $58.28M | $86.08M | $97.23M | $75.73M | $681.91M | $45.99M | $28.39M | $11.04M |
| Changes in Working Capital: | ||||||||
| Accounts Receivable | $1.69M | -$3.37M | -$1.38M | -$8.68M | -$6.88M | $0 | $0 | $0 |
| Inventory | $2.62M | $3.07M | -$1.94M | -$14.08M | -$5.67M | $0 | $0 | $0 |
| Accounts Payable | -$2.73M | -$14.63M | $2.89M | $2.34M | $1.3M | $0 | -$6.55M | -$338K |
| Other Working Capital | $10.84M | -$9.35M | $8.15M | $5.95M | $32.85M | $17.22M | -$32.74M | $40.01M |
| Total Working Capital Change | $12.41M | -$24.28M | $7.72M | -$14.46M | $21.59M | $17.22M | -$39.28M | $39.67M |
| Other Non-Cash Items | $8.46M | $1.36B | $644.38M | $4.66B | -$201M | $9.38M | -$353K | $1.66M |
| Net Cash from Operating | -$299.01M | -$577.16M | -$595.8M | -$561.31M | -$688.13M | -$232M | -$245.79M | -$209.26M |
| Investing Activities | ||||||||
| Capital Expenditures | -$909K | -$5.21M | -$12.89M | -$22.86M | -$69.93M | -$11.9M | -$3.33M | -$15.99M |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$1.31B | -$545.8M | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $1.22B | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $414.74M | -$885K | $136.37M | -$77.4M |
| Net Cash from Investing | -$85.05M | -$551.01M | -$12.89M | -$22.86M | $344.81M | -$12.79M | $133.04M | -$93.39M |
| Financing Activities | ||||||||
| Debt Repaid | - | - | - | - | - | $812K | $1.56M | $1.51M |
| Common Stock Issuance | $423.32M | $0 | $0 | $0 | $5.98M | $0 | $0 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | -$170K | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $1.24B | $463.77M | $604.82M | $388.93M | $275.92M | $161.88M | $302.13M |
| Net Cash from Financing | $423.32M | $1.24B | $463.77M | $604.82M | $394.74M | $275.11M | $160.33M | $300.62M |
| Forex Effect | -$147K | -$62K | $305K | -$511K | -$194.61M | $36K | $124K | $483K |
| Net Change in Cash | $39.12M | $116.07M | -$144.62M | $20.13M | -$143.19M | $30.35M | $47.69M | -$1.55M |
| Supplementary Data | ||||||||
| Operating Cash Flow | -$299.01M | -$577.16M | -$595.8M | -$561.31M | -$688.13M | -$232M | -$245.79M | -$209.26M |
| Capital Expenditure | -$909K | -$5.21M | -$12.89M | -$22.86M | -$69.93M | -$11.9M | -$3.33M | -$15.99M |
| Free Cash Flow | -$299.01M | -$582.36M | -$608.69M | -$584.17M | -$758.06M | -$243.91M | -$249.13M | -$225.25M |
| Cash at Beginning | $217.58M | $101.51M | $246.13M | $225.99M | $143.19M | $144.42M | $96.72M | $98.27M |
| Cash at End | $256.7M | $217.58M | $101.51M | $246.13M | $0 | $174.77M | $144.42M | $96.72M |